🟢 99/100

This product looks safe

  • Niacin: 60mg is 1.7× the Tolerable Upper Intake Level (35mg)
  • 47% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Niacin: 60mg is 1.7× the Tolerable Upper Intake Level (35mg)

Label Data

2 Tablet(s) Serving Size
Other Combinations Product Type
47% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin A
2000 IU (40% DV)
Vitamin C
120 mg (200% DV)
50 IU (13% DV)
✅ Within RDA (0.1× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.00125mg UL 0.1mg
4 mg (266% DV)
📊 3.3× RDA — above typical dose 📚 76 studies (Tier A: 0, B: 33)
RDA 1.2mg This product: 4mg
4 mg (235% DV)
📊 3.1× RDA — above typical dose 📚 12 studies (Tier A: 0, B: 1)
RDA 1.3mg This product: 4mg
60 mg (300% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.7× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 60mg UL 35mg
4 mg (200% DV)
📊 3.1× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 4mg UL 100mg
10 mcg (167% DV)
📊 4.2× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.01mg
40 mg (400% DV)
📊 8.0× RDA — above typical dose 📚 1 studies — no high-quality reviews
RDA 5mg This product: 40mg
Calcium
160 mg (16% DV)
120 mg (30% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 120mg
6 mg (40% DV)
✅ Within RDA (0.5× RDA of 11 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 6mg UL 40mg
40 mcg (57% DV)
✅ Within RDA (0.7× RDA of 0.055 mg) 📚 172 studies (Tier A: 0, B: 67)
RDA 0.055mg This product: 0.04mg UL 0.4mg
8 mg (400% DV)
📊 3.5× RDA — above typical dose (UL: 11 mg) 📚 8 studies — no high-quality reviews
RDA 2.3mg This product: 8mg UL 11mg
60 mcg (50% DV)
✅ 1.7× RDA — within safe limits 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.06mg
Potassium
110 mg (3.14% DV)
📊 Market median: 500.0mg (497 products) 📚 132 studies (Tier A: 0, B: 40)
This product: 160mg
160 mg
📊 Market median: 500.0mg (180 products) 📚 5 studies (Tier A: 0, B: 1)
This product: 160mg
📊 Market median: 333.0mg (166 products) 📚 9 studies (Tier A: 0, B: 2)
This product: 94mg
Beta-sitosterol Complex
70 mg
Horsetail Leaf
60 mg
Juniper berry
60 mg
60 mg
📊 Market median: 300.0mg (214 products) 📚 23 studies (Tier A: 0, B: 6)
This product: 60mg
Cayenne
50 mg
50 mg
📊 Market median: 500.0mg (19 products)
This product: 50mg
50 mg
📊 Market median: 496.0mg (192 products) 📚 20 studies — no high-quality reviews
This product: 50mg
Polygonum cuspidatum root extract
6.66 mg
Co Q-10
3.34 mg
Bronson BioAccelerators
7.66 mg

Other Ingredients

Cellulose Stearic Acid Magnesium Stearate Silica Aqueous Tablet Coating

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (76% of products) Nutrient (58% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

DIRECTIONS: As a dietary supplement for adults, take 2 tablets 3 times daily with meals or as directed by a healthcare professional.

⚠️ Warnings & Precautions

WARNING: If you are pregnant, nursing, taking any medications or planning any medical procedure, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Keep out of reach of children.

If you are currently taking a diuretic or other medication, seek the advice of your healthcare professional before taking this product.

🧪 Formulation Notes

Contains soy.

Additional Information

F1112504 EXP.11/2013

Store in a cool, dry place. Protect from light.

Made in USA

No. 904A REF 0610

NUTRITIONALLY SUPPORTS CARDIOVASCULAR FUNCTION

Product Details

UPC / SKU 7 16563 90401 2
DSLD Entry Date 2012-04-26
Product Type Other Combinations
Form Tablet or Pill
Brand Bronson
DSLD ID 8231
Data Updated 2026-04-11

Research Evidence

337 Research Sources
54 Avg Quality Score
161 Meta Analysis
68 Systematic Review
51 Rct
48 Clinical Trial
2 Other
2 Regulatory Source
1 Narrative Review
1 Cochrane Review
1 Guideline
1 Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024
View all evidence for Vitamin A →

Compare Similar Products

View all Vitamin A products →